Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Diseases

Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.

598 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Diseases trial results

Completed

Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women

NCT01227928

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Nanjing, Jiangsu, China
  • GSK Investigational Site Shenyang, Liaoning, China
  • GSK Investigational Site Jinan, Shandong, China
View all 15 locations
View Trial Details
Completed

Pharmacogenomics of Paclitaxel in Ovarian Cancer

NCT00415181

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Department of oncology, Herlev Hospital Herlev, Denmark
  • Department of Oncology, Odense University Hospital Odense, Denmark
  • Department of Oncology, Vejle Hospital Vejle, Denmark
  • Department of Oncology, University Hospital of Lund Lund, Sweden
View Trial Details
Completed

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

NCT00814086

Conditions
Adnexal Diseases, Brenner Tumor, Chemically-Induced Disorders, +40 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Cooper Hospital University Medical Center Camden, New Jersey, United States
  • Riverside Methodist Hospital Columbus, Ohio, United States
View Trial Details
Completed

Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

NCT00352300

Conditions
Adnexal Diseases, Agranulocytosis, Communicable Diseases, +32 more
Locations
  • University of California Medical Center At Irvine-Orange Campus Orange, California, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Cooper Hospital University Medical Center Camden, New Jersey, United States
  • New York University Langone Medical Center New York, United States
View Trial Details
Completed

TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

NCT01294293

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +31 more
Locations
  • Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View Trial Details
Completed

S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission

NCT00003120

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
View all 93 locations
View Trial Details

Related conditions